Digestive and Liver Disease
Volume 44, Issue 4 , Pages 303-310, April 2012

Metabolomic profiling of 17 bile acids in serum from patients with primary biliary cirrhosis and primary sclerosing cholangitis: A pilot study

  • Jocelyn Trottier

      Affiliations

    • Laboratory of Molecular Pharmacology, CHUQ Research Center and the Faculty of Pharmacy, Laval University, Québec, Canada
  • ,
  • Andrzej Białek

      Affiliations

    • Department of Gastroenterology, Pomeranian Medical University, Szczecin, Poland
  • ,
  • Patrick Caron

      Affiliations

    • Laboratory of Molecular Pharmacology, CHUQ Research Center and the Faculty of Pharmacy, Laval University, Québec, Canada
  • ,
  • Robert J. Straka

      Affiliations

    • Experimental and Clinical Pharmacology Department, College of Pharmacy, University of Minnesota, Minneapolis, USA
  • ,
  • Jenny Heathcote

      Affiliations

    • Toronto Western Hospital, University Health Network, Toronto, Canada
  • ,
  • Piotr Milkiewicz

      Affiliations

    • Liver Unit and Liver Research Laboratories, Pomeranian Medical University, Szczecin, Poland
  • ,
  • Olivier Barbier

      Affiliations

    • Laboratory of Molecular Pharmacology, CHUQ Research Center and the Faculty of Pharmacy, Laval University, Québec, Canada
    • Corresponding Author InformationCorresponding author at: Laboratory of Molecular Pharmacology, CHUQ Research Center, 2705 Laurier Boulevard, Québec (QUE), G1V 4G2 Canada. Tel.: +1 418 654 2296; fax: +1 418 654 2761.

Received 2 March 2011; accepted 30 October 2011. published online 12 December 2011.

Abstract 

Background

Primary biliary cirrhosis and primary sclerosing cholangitis are two cholestatic diseases characterised by hepatic accumulation of bile acids.

Aims

This study compares serum bile acid levels in patients with primary biliary cirrhosis and primary sclerosing cholangitis and from age and sex-matched non cholestatic donors.

Methods

Seventeen bile acids were quantified using liquid chromatography coupled to tandem mass spectrometry. Serum samples from cholestatic patients were compared with those of non-cholestatic donors.

Results

The concentration of total bile acids, taurine and glycine conjugates of primary bile acids was elevated in both patients with primary biliary cirrhosis and primary sclerosing cholangitis when compared to non-cholestatic donors. Samples from primary sclerosing cholangitis patients displayed reduced levels of secondary acids, when compared to non cholestatic and primary biliary cirrhosis sera. The ratio of total glycine versus total taurine conjugates was reduced in patients with primary biliary cirrhosis, but not in primary sclerosing cholangitis.

Conclusion

The present study suggests that circulating bile acids are altered differentially in primary biliary cirrhosis and primary sclerosing cholangitis patients.

Keywords: Cholestasis, LC–MS/MS, Primary biliary cirrhosis, Primary sclerosing cholangitis, Plasma bile acids

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Grant support: This study was supported by grants from the Canadian Institute of Health Research (CIHR; grant #MOP-84338) and the Canadian Foundation for Innovation (CFI, grant #10469). J. Trottier is holder of a scholarship from CIHR. O. Barbier is holder of a salary grant from CIHR (New investigator award #MSH95330) and the “Fonds pour la Recherche en Santé du Québec, FRSQ” (junior II award). The GOLDN study was supported by the NIH Heart, Lung and Blood Institute Grant U 01 HL72524, Genetic and Environmental Determinants of Triglycerides.

PII: S1590-8658(11)00425-7

doi:10.1016/j.dld.2011.10.025

Digestive and Liver Disease
Volume 44, Issue 4 , Pages 303-310, April 2012